Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical detection of EGFR mutation using mutation-specific antibodies in lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jul 2010

Kitamura Atsuko, Hosoda Waki, Sasaki Eiichi, Mitsudomi Tetsuya, Yatabe Yasushi

Abstract excerpt

PURPOSE: Patients with mutations of epidermal growth factor receptor (EGFR) receive more benefit from EGFR-tyrosine kinase inhibitor treatment. However, usually such treatment is used to treat advanced lung cancer and only small biopsy samples are available for mutational analysis. We used immuno...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Antibody Specificity
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gefitinib

Share to Gene Amplification

Share to Protein Kinase Inhibitors

Share to Quinazolines

Source

Identifiers

PMID: 20570926
DOI: 10.1158/1078-0432.CCR-10-0129

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20570926-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical detection of EGFR mutation using mutation-specific antibodies in lung cancer.PMID 20570926Read ↗

Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies.Semantic proximity Read ↗

Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis.Semantic proximity Read ↗

[Value of immunohistochemical staining with mutation-specific antibodies in detecting EGFR mutations: a meta-analysis].Semantic proximity Read ↗

Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.Semantic proximity Read ↗

Overexpression of mutant EGFR protein indicates a better survival benefit from EGFR-TKI therapy in non-small cell lung cancer.Semantic proximity Read ↗

[Immunohistochemical detections of EGFR mutations in NSCLC].Semantic proximity Read ↗

Molecular diagnosis of activating EGFR mutations in non-small cell lung cancer using mutation-specific antibodies for immunohistochemical analysis.Semantic proximity Read ↗

Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.Semantic proximity Read ↗

[Immunohistochemical detections of EGFR status in NSCLC].Semantic proximity Read ↗

Immunostaining with EGFR mutation-specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples.Semantic proximity Read ↗

Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.Semantic proximity Read ↗

Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.